Association of Smoking with the Severity of H. pylori with the Extent of Its Impact on Blood Parameters

Document Type : Original Articles


1 Genetic, College of Science, University of Diyala, Diyala, Iraq

2 Institute of Medical Technology Al-Mansur, Middle Technical University, Baghdad, Iraq

3 Molecular Cytology and Cell Culture, College of Medicine, University of Diyala, Diyala, Iraq


pylori infection is considered a major global gastric disorder. Furthermore, the spread of H. pylori infection and its effect on systemic disorders and blood is not fully understood. On the other hand, the high percentage of smokers and their impacts on the health system have become a significant concern. Therefore, the current study aimed to compare the H. pylori infection in smokers and non-smokers and their effects on hematological parameters.190 patients participated and were divided into two groups; 95 were smokers and 95 were non-smokers. The Helicobacter pylori detector instrument showed that the participants were infected. Vein blood was collected to check hematological parameters via a fully automatic hematological analyzer (DIAGON Ltd.-D-Cell 60). The recorded data showed that the highest percentage of infected patients was 26–45 years in both smokers and non-smokers (P≤0.05). Furthermore, depending on the residence, our study revealed that the urban cases were the highest percentage compared to rural cases (P≤0.05). The hematological parameters showed that RBCs, Hb, PCV, MCV, MCH, and MCHC were significantly higher in smokers compared with non-smokers (P≤0.05).


Main Subjects

  1. Li Z, Zou D, Ma X, Chen J, Shi X, Gong Y, et al. Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China. Am J Gastroenterol. 2010;105(12):2570-7.
  2. Isaacson PG, Spencer J. Is gastric lymphoma an infectious disease? 1993. p. 569-70.
  3. Tsang KW, Lam SK. Helicobacter pylori and extra‐digestive diseases. J Gastroenterol Hepatol. 1999;14(9):844-50.
  4. Ruggiero P. Helicobacter pylori and inflammation. Curr Pharm Des. 2010;16(38):4225-36.
  5. Kusters JG, Van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19(3):449-90.
  6. Nakagawa H, Tamura T, Mitsuda Y, Goto Y, Kamiya Y, Kondo T, et al. Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults. Mediators Inflamm. 2013;2013.
  7. Lobbes M, Lutgens E, Heeneman S, Cleutjens K, Kooi M, van Engelshoven J, et al. Is there more than C-reactive protein and fibrinogen?: The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis. 2006;187(1):18-25.
  8. Salman MA, Rashid H. Impact of smoking on hematological parameters in hypertension smokers. Int J Psychosoc Rehabilitation. 2020;24(06).
  9. Metrics IIfH, Evaluation. GBD compare data visualization. University of Washington Seattle; 2016.
  10. Li L, Chan R, Lu L, Shen J, Zhang L, Wu W, et al. Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms. Int J Mol Med. 2014;34(2):372-80.
  11. Brenner H, Rothenbacher D, Bode G, Adler G. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. BMJ. 1997;315(7121):1489-92.
  12. Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, et al. Smoking behavior and risk of Helicobacter pylori infection, gastric atrophy and gastric cancer in Japanese. Asian Pac J Cancer Prev. 2010;11(3):669-73.
  13. Santibáñez M, Aguirre E, Belda S, Aragones N, Saez J, Rodríguez JC, et al. Relationship between tobacco, cagA and vacA i1 virulence factors and bacterial load in patients infected by Helicobacter pylori. PLoS One. 2015;10(3):0120444.
  14. IARC. A Review of Human Carcinogens. F. Chemical Agents and Related Occupations: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2012.
  15. Peleteiro B, La Vecchia C, Lunet N. The role of Helicobacter pylori infection in the web of gastric cancer causation. Eur J Cancer Prev. 2012;21(2):118-25.
  16. Itskoviz D, Boltin D, Leibovitzh H, Perets TT, Comaneshter D, Cohen A, et al. Smoking increases the likelihood of Helicobacter pylori treatment failure. Dig Liver Dis. 2017;49(7):764-8.
  17. Suzuki T, Matsuo K, Ito H, Sawaki A, Hirose K, Wakai K, et al. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med. 2006;119(3):217-24.
  18. Leja M, Axon A, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016;21:3-7.
  19. Sjomina O, Pavlova J, Niv Y, Leja M. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018;23:12514.
  20. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298(22):2654-64.
  1. WHO, Ageing WHO, Unit LC. WHO global report on falls prevention in older age: World Health Organization; 2008.
  2. Mwafy SN, Afana WM. Hematological parameters, serum iron and vitamin B 12 levels in hospitalized Palestinian adult patients infected with Helicobacter pylori: a case–control study. Hematol Transfus Cell Ther. 2018;40:160-5.
  3. Ciacci C, Sabbatini F, Cavallaro R, Castiglione F, Di Bella S, Iovino P, et al. Helicobacter pylori impairs iron absorption in infected individuals. Dig Liver Dis. 2004;36(7):455-60.
  4. Morris RW, Taylor AE, Fluharty ME, Bjørngaard JH, Åsvold BO, Gabrielsen ME, et al. Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium. BMJ Open. 2015;5(8):008808.
  5. Blumenthal I. Carbon monoxide poisoning. J R Soc Med. 2001;94(6):270-2.